Disclosed are novel proteins, referred to as truncated glial cell
line-derived neurotrophic factor (truncated GDNF) proteins, that promote
dopamine uptake by dopaminergic cells and promote the survival of nerve
cells. Also disclosed are processes for obtaining the truncated GDNF
proteins by recombinant genetic engineering techniques.